Pacific Global Investment Management’s Pfizer PFE Stock Holding History

Pacific Global Investment Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-25,681	Closed	-$743K	–	165
2024 Q3	$743K	Sell	25,681 -2,084	-8%	-$60.8K	0.13%	116
2024 Q2	$777K	Sell	27,765 -6,259	-18%	-$172K	0.15%	112
2024 Q1	$944K	Sell	34,024 -10,704	-24%	-$297K	0.18%	99
2023 Q4	$1.29M	Sell	44,728 -7,065	-14%	-$214K	0.26%	85
2023 Q3	$1.72M	Sell	51,793 -1,691	-3%	-$59.8K	0.38%	64
2023 Q2	$1.96M	Buy	53,484 +1,553	+3%	+$60.4K	0.41%	59
2023 Q1	$2.12M	Buy	51,931 +181	+0.3%	+$7.82K	0.46%	51
2022 Q4	$2.65M	Buy	51,750 +134	+0.3%	+$6.42K	0.59%	46
2022 Q3	$2.26M	Buy	51,616 +910	+2%	+$44.2K	0.55%	47
2022 Q2	$2.66M	Sell	50,706 -692	-1%	-$35.3K	0.63%	45
2022 Q1	$2.66M	Sell	51,398 -692	-1%	-$35.9K	0.52%	49
2021 Q4	$3.08M	Buy	52,090 +99	+0.2%	+$4.91K	0.57%	43
2021 Q3	$2.24M	Sell	51,991 -2,424	-4%	-$107K	0.45%	51
2021 Q2	$2.13M	Sell	54,415 -2,101	-4%	-$81.7K	0.42%	59
2021 Q1	$2.05M	Sell	56,516 -5,283	-9%	-$188K	0.43%	60
2020 Q4	$2.27M	Buy	61,799 +6,526	+12%	+$239K	0.5%	47
2020 Q3	$1.93M	Buy	55,273 +4,140	+8%	+$145K	0.5%	49
2020 Q2	$1.59M	Sell	51,133 -3,977	-7%	-$135K	0.45%	57
2020 Q1	$1.71M	Sell	55,110 -9,458	-15%	-$322K	0.54%	47
2019 Q4	$2.4M	Sell	64,568 -589	-0.9%	-$21K	0.52%	55
2019 Q3	$2.22M	Buy	65,157 +4,817	+8%	+$175K	0.52%	59
2019 Q2	$2.48M	Sell	60,340 -2,622	-4%	-$104K	0.58%	56
2019 Q1	$2.54M	Sell	62,962 -108	-0.2%	-$4.33K	0.56%	59
2018 Q4	$2.61M	Sell	63,070 -341	-0.5%	-$14.2K	0.65%	49
2018 Q3	$2.65M	Sell	63,411 -269	-0.4%	-$10.4K	0.54%	61
2018 Q2	$2.19M	Sell	63,680 -1,052	-2%	-$36K	0.48%	69
2018 Q1	$2.18M	Buy	64,732 +102	+0.2%	+$3.51K	0.49%	64
2017 Q4	$2.22M	Sell	64,630 -2,963	-4%	-$101K	0.48%	64
2017 Q3	$2.29M	Buy	67,593 +409	+0.6%	+$13.1K	0.52%	60
2017 Q2	$2.14M	Sell	67,184 -609	-0.9%	-$19.2K	0.49%	68
2017 Q1	$2.2M	Sell	67,793 -2,859	-4%	-$90.1K	0.44%	78
2016 Q4	$2.18M	Sell	70,652 -811	-1%	-$24.8K	0.44%	75
2016 Q3	$2.3M	Buy	71,463 +6,093	+9%	+$204K	0.51%	64
2016 Q2	$2.18M	Buy	65,370 +7,130	+12%	+$228K	0.51%	68
2016 Q1	$1.64M	Buy	58,240 +8,663	+17%	+$247K	0.37%	87
2015 Q4	$1.52M	Buy	49,577 +6,878	+16%	+$216K	0.34%	94
2015 Q3	$1.27M	Sell	42,699 -358	-0.8%	-$11.5K	0.28%	102
2015 Q2	$1.37M	Buy	43,057 +79	+0.2%	+$2.58K	0.26%	99
2015 Q1	$1.42M	Buy	42,978 +1,602	+4%	+$50.9K	0.26%	94
2014 Q4	$1.22M	Sell	41,376 -537	-1%	-$15.4K	0.21%	102
2014 Q3	$1.18M	Sell	41,913 -656	-2%	-$18.4K	0.19%	99
2014 Q2	$1.2M	Sell	42,569 -6,088	-13%	-$174K	0.18%	101
2014 Q1	$1.48M	Buy	48,657 +5,923	+14%	+$177K	0.23%	83
2013 Q4	$1.24M	Buy	42,734 +3,423	+9%	+$99.6K	0.2%	91
2013 Q3	$1.07M	Buy	39,311 +213	+0.5%	+$5.79K	0.21%	98
2013 Q2	$1.04M	Buy	+39,098	New	+$1.08M	0.19%	88

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pacific Global Investment Management's PFE Position: Q4 2024 in Review

Pacific Global Investment Management sold out of Pfizer (PFE) in Q4 2024, closing a stake of 25,681 shares — an estimated $743K sold.

Pacific Global Investment Management first reported a position in PFE in Q2 2013 and held it in 46 quarters. The position peaked at $3.08M in Q4 2021. 2,996 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

Pacific Global Investment Management reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
Pacific Global Investment Management sold 25,681 Pfizer shares in Q4 2024, an estimated $743K.
Pacific Global Investment Management first reported a position in Pfizer in Q2 2013 and held it in 46 quarters.
Pacific Global Investment Management's Pfizer position peaked at $3.08M in Q4 2021.
2,996 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Pacific Global Investment Management's 13F filing for Q4 2024, filed 6 Feb 2025.